A HERITAGE OF INNOVATION AND LEADERSHIP
Lantheus Medical Imaging, a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease.
Our proven success in discovering, developing and commercializing innovative medical imaging agents provides a strong platform from which to bring forward breakthrough new tools for the diagnosis and management of disease. Lantheus has a rich heritage and expertise in cardiovascular imaging and nuclear medicine, having pioneered many of the most significant products used in medical imaging.
Our current imaging agents primarily assist in the diagnosis of heart, vascular and other diseases using nuclear imaging, echocardiography and magnetic resonance imaging (MRI) technologies. We also have a full clinical and preclinical development pipeline of next-generation and first-in-class products using Positron Emission Tomography (PET) and MRI technologies.
Our vision is to be the leading provider of innovative medical imaging solutions to improve human life. We are committed to developing next generation and first-in-class imaging agents to assist physicians in the diagnosis of heart, vascular and other diseases.
With direct operations in the United States, Puerto Rico, Canada and Australia, we have a long and distinguished history of developing and commercializing innovative market-changing products.
Quarterly SEC Filings
Lantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 p.m. Eastern Time
Lantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study
Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ICNC 11th Annual Meeting
Lantheus Medical Imaging Realigns Executive Leadership Team
Q1 2013 Lantheus Medical Earnings Conference Call (Live)
Tuesday, May 14, 2013 at
4:00 p.m. ET
Lantheus Medical Imaging to Host First Quarter 2013 Conference Call
on May 14, 2013
4:00 p.m. Eastern Time
N. Billerica, Mass., May 7, 2013 – Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Tuesday, May 14, 2013, to discuss its financial and operating results for the first quarter of 2013.
click here for the press release